DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹358 Cr | ₹239 Cr | ₹345 Cr | ₹292 Cr | ₹226 Cr |
What is the latest Consolidated Net Profit of DR LAL PATHLABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹358 Cr |
| Mar2024 | ₹239 Cr |
| Mar2023 | ₹345 Cr |
| Mar2022 | ₹292 Cr |
| Mar2021 | ₹226 Cr |
How is Consolidated Net Profit of DR LAL PATHLABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹358 Cr | 49.78 | |
| Mar2024 | ₹239 Cr | -30.74 | |
| Mar2023 | ₹345 Cr | 18.25 | |
| Mar2022 | ₹292 Cr | 29.07 | |
| Mar2021 | ₹226 Cr | - | |
Compare Consolidated Net Profit of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹23,570.4 Cr | 0.5% | 0.6% | 7.1% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹109,102.0 Cr | 0.7% | 11.1% | 20% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹105,196.0 Cr | 2.6% | 7.6% | 8.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹68,444.5 Cr | -1.1% | 7.4% | 49.4% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹37,523.7 Cr | 0.8% | 1.1% | 38.8% | Stock Analytics | |
| GLOBAL HEALTH | ₹30,615.2 Cr | 0.5% | 8.7% | 4.4% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 0.5% |
0.6% |
7.1% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses